Research map: HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma
Back to the article
Papers in this map
An integrated encyclopedia of DNA elements in the human genome
· Ian Dunham · 2012 · 19875 citations · Cited by this paper
Unveiling the unique interaction mechanism of herpes simplex virus 2 glycoprotein C with C3b
· 2026 · Related
GSVA: gene set variation analysis for microarray and RNA-Seq data
· Sonja Hänzelmann · 2013 · 17099 citations · Cited by this paper
IL-2(N88D)/CD25 Fusion Protein Enhances Expansion of Antigen-Specific CD8⁺ T Cells to Suppress Hepatocellular Carcinoma
· 2026 · Related
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
· Malcolm J. Moore · 2007 · 3889 citations · Cited by this paper
Auditory network persistence of stimulus representation in awake and naturally sleeping mice
· 2026 · Related
Genomic analyses identify molecular subtypes of pancreatic cancer
· Peter J. Bailey · 2016 · 3805 citations · Cited by this paper
CCR7-PERK-CREB3L1 signaling mediates tumor-associated macrophages-derived SPP1 promotion of oral squamous cell carcinoma
· 2026 · Related
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
· Kenneth P. Olive · 2009 · 3202 citations · Cited by this paper
Graph-based representation learning of neuronal dynamics and behavior
· 2026 · Related
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
· Jake E. Delmore · 2011 · 2889 citations · Cited by this paper
ArgR regulates the nrf operon to defend against nitrosative and oxidative stress in Aeromonas veronii
· 2026 · Related
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
· Richard A. Moffitt · 2015 · 2315 citations · Cited by this paper
A scalable subject-specific manifold learning framework for neuroimaging data
· 2026 · Related
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
· Eric Andrew Collisson · 2011 · 2065 citations · Cited by this paper
RBM15 impairs Hepatic Mitochondria and β-Oxidation through m6A-dependent degradation of MCM3 mRNA
· 2026 · Related
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
· Johannes A. Zuber · 2011 · 1899 citations · Cited by this paper
BMI-driven multi-omics analysis profiles the molecular mechanism of psycho-metabolic nexus and contributes to risk stratification
· 2026 · Related
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
· P. Filippakopoulos · 2012 · 1793 citations · Cited by this paper
Metatranscriptomics reveals urbanization-driven divergence in rodent viromes and zoonotic risks in Chinese megacities
· 2026 · Related
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
· Mark A. Dawson · 2011 · 1542 citations · Cited by this paper
Targeting MYC dependence in cancer by inhibiting BET bromodomains
· Jennifer A. Mertz · 2011 · 1127 citations · Cited by this paper
TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues
· Áron Bartha · 2021 · 1119 citations · Cited by this paper
Plasticity in binding confers selectivity in ligand-induced protein degradation
· Radosław P. Nowak · 2018 · 646 citations · Cited by this paper
BET inhibitor resistance emerges from leukaemia stem cells
· Chun Yew Fong · 2015 · 556 citations · Cited by this paper
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
· Philipp Rathert · 2015 · 526 citations · Cited by this paper
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
· Omer Gilan · 2020 · 446 citations · Cited by this paper
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
· Emily J. Faivre · 2020 · 415 citations · Cited by this paper
Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors
· Jaclyn Andricovich · 2018 · 334 citations · Cited by this paper
Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression
· Tikvah K. Hayes · 2015 · 283 citations · Cited by this paper
Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3
· Ethan V. Abel · 2013 · 246 citations · Cited by this paper
TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma
· Tim D.D. Somerville · 2018 · 240 citations · Cited by this paper
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
· Elisa M. Noll · 2016 · 234 citations · Cited by this paper
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer
· Mark L. McCleland · 2016 · 232 citations · Cited by this paper
MCT4 Defines a Glycolytic Subtype of Pancreatic Cancer with Poor Prognosis and Unique Metabolic Dependencies
· GuemHee Baek · 2014 · 228 citations · Cited by this paper
Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy
· Zhiqiang Wang · 2023 · 213 citations · Cited by this paper
KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism
· Angelina V. Vaseva · 2018 · 196 citations · Cited by this paper
Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
· Elisabeth Heßmann · 2016 · 145 citations · Cited by this paper
The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models
· Patrick L. Garcia · 2015 · 135 citations · Cited by this paper
Source: OpenAlex (CC0)